Abstract
The aim of this study was to analyze the influence of neoadjuvant treatment on nodal harvest after rectal cancer surgery and its impact on long-term oncological outcomes. A retrospective analysis of patients with rectal cancer who received curative intent treatment from 2002 to 2012 in our institution was performed. Data on various clinic-pathological and treatment details were recovered from the records. The number of nodes harvested after surgery was analyzed. The influence of number of nodes harvested on overall survival and disease free survival was analyzed. Among the 459 patients included in this study, 326 underwent surgery after neoadjuvant treatment (NAT). The mean number of nodes harvested was significantly lower in patients who received NAT compared with those who did not (8.9 ± 5.77 vs 14 ± 9.84, p < 0.001). However, the mean number of pathologically positive nodes was not significantly different. A minimum of 12 nodes were harvested in only 27.9% of patients who received NAT. No lymph nodes were identified in the specimen in 15 patients (4.6%) who underwent surgery after NAT. The only independent factors influencing harvest of a minimum of 12 nodes were patient age and NAT. The 5-year overall survival was not significantly different in patients in whom < 12 or ≥ 12 nodes were harvested (64% vs 69% respectively, p = 0.5). Neoadjuvant chemoradiation significantly reduces nodal harvest in patients undergoing treatment for rectal cancer. However, this reduced nodal harvest did not adversely impact survival in patients. However, every effort must be made by the surgeon and the pathologist to maximize the nodal harvest.
Similar content being viewed by others
References
Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R (2004) German rectal cancer study G. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–1740. https://doi.org/10.1056/NEJMoa040694
Kim TH, Chang HJ, Kim DY, Jung KH, Hong YS, Kim SY, Park JW, Oh JH, Lim SB, Choi HS, Jeong SY (2010) Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Int J Radiat Oncol Biol Phys 77(4):1158–1165. https://doi.org/10.1016/j.ijrobp.2009.06.019
Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson AB 3rd, Cummings B, Gunderson L, Macdonald JS, Mayer RJ (2001) Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19(1):157–163. https://doi.org/10.1200/JCO.2001.19.1.157
Milburn Jessup J, Richard M. Goldberg, Elliot A. Asare et al (2017) AJCC cancer staging manual, Eighth edn. (editor in chief Mahul B. Amin), Springer USA. https://doi.org/10.1007/978-3-319-40618-3_20
Mekenkamp LJ, van Krieken JH, Marijnen CA, van de Velde CJ, Nagtegaal ID Pathology Review C, the Co-operative Clinical I. Lymph node retrieval in rectal cancer is dependent on many factors--the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol 33(10):1547–1553. https://doi.org/10.1097/PAS.0b013e3181b2e01f
Morris EJ, Maughan NJ, Forman D, Quirke P (2007) Identifying stage III colorectal cancer patients: the influence of the patient, surgeon, and pathologist. J Clin Oncol 25(18):2573–2579. https://doi.org/10.1200/JCO.2007.11.0445
Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2(8514):996–999
Mechera R, Schuster T, Rosenberg R, Speich B (2017) Lymph node yield after rectal resection in patients treated with neoadjuvant radiation for rectal cancer: a systematic review and meta-analysis. Eur J Cancer 72:84–94. https://doi.org/10.1016/j.ejca.2016.10.031
Damin DC, Rosito MA, Contu PC, Tarta C, Ferreira PR, Kliemann LM, Schwartsmann G (2012) Lymph node retrieval after preoperative chemoradiotherapy for rectal cancer. J Gastrointest Surg 16(8):1573–1580. https://doi.org/10.1007/s11605-012-1916-4
Baxter NN, Morris AM, Rothenberger DA, Tepper JE (2005) Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys 61(2):426–431. https://doi.org/10.1016/j.ijrobp.2004.06.259
Rullier A, Laurent C, Capdepont M, Vendrely V, Belleannee G, Bioulac-Sage P, Rullier E (2008) Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol 32(1):45–50. https://doi.org/10.1097/PAS.0b013e3180dc92ab
Marks JH, Valsdottir EB, Rather AA, Nweze IC, Newman DA, Chernick MR (2010) Fewer than 12 lymph nodes can be expected in a surgical specimen after high-dose chemoradiation therapy for rectal cancer. Dis Colon Rectum 53(7):1023–1029. https://doi.org/10.1007/DCR.0b013e3181dadeb4
Li Destri G, Di Carlo I, Scilletta R, Scilletta B, Puleo S (2014) Colorectal cancer and lymph nodes: the obsession with the number 12. World J Gastroenterol 20(8):1951–1960. https://doi.org/10.3748/wjg.v20.i8.1951
Seshadri RA, Srinivasan A, Tapkire R, Swaminathan R (2012) Laparoscopic versus open surgery for rectal cancer after neoadjuvant chemoradiation: a matched case-control study of short-term outcomes. Surg Endosc 26:154–161. https://doi.org/10.1007/s00464-011-1844-5
Evans MD, Barton K, Rees A, Stamatakis JD, Karandikar SS (2008) The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease. Color Dis 10(2):157–164. https://doi.org/10.1111/j.1463-1318.2007.01225.x
Hamza A, Sakhi R, Khawar S, Alrajjal A, Edens J, Khurram MS, Khan U, Szpunar S, Mazzara P (2018) Role of “second look” lymph node search in harvesting optimal number of lymph nodes for staging of colorectal carcinoma. Gastroenterol Res Pract 1985031:1–6. https://doi.org/10.1155/2018/1985031
Habr-Gama A, Perez RO, Proscurshim I, Rawet V, Pereira DD, Sousa AH, Kiss D, Cecconello I (2008) Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum 51(3):277–283. https://doi.org/10.1007/s10350-007-9148-5
Kim YW, Kim NK, Min BS, Lee KY, Sohn SK, Cho CH, Kim H, Keum KC, Ahn JB (2009) The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer. J Surg Oncol 100(1):1–7. https://doi.org/10.1002/jso.21299
Lee WS, Lee SH, Baek JH, Lee WK, Lee JN, Kim NR, Park YH (2013) What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer. Radiat Oncol 8:202. https://doi.org/10.1186/1748-717X-8-202
Kim WR, Han YD, Cho MS, Hur H, Min BS, Lee KY, Kim NK (2015) Oncologic impact of fewer than 12 lymph nodes in patients who underwent neoadjuvant chemoradiation followed by total mesorectal excision for locally advanced rectal cancer. Medicine (Baltimore) 94(28):e1133. https://doi.org/10.1097/MD.0000000000001133
Acknowledgements
We wish to acknowledge the services of Dr. Rajaraman Swaminathan and Mrs. Kalyani, Department of Epidemiology, Biostatistics and Cancer Registry, Cancer Institute (WIA), Chennai, for their invaluable help with the statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Billakanti, R., Seshadri, R.A., Soma, S. et al. Lymph Node Harvest After Neoadjuvant Treatment for Rectal Cancer and Its Impact on Oncological Outcomes. Indian J Surg Oncol 11, 692–698 (2020). https://doi.org/10.1007/s13193-020-01162-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-020-01162-y